LONDON (ShareCast) - (Sharecast News) - One Health Group posted strong interim results on Monday, reporting double-digit increases in revenue, profit and activity levels as NHS waiting list pressures continued to support demand for outsourced surgical capacity.
The AIM-traded independent provider of NHS-funded procedures said performance in the six months ended 30 September was in line with expectations, with growth recorded across all operational and financial metrics.

Revenue rose 18% year on year to £15.6m, while gross profit increased 35% to £3.12m.

Underlying EBITDA advanced 23% to £1.18m and cash balances more than doubled to £10.9m, reflecting proceeds from the group's March AIM float and land purchase for its first surgical hub.

It said underlying earnings per share declined 8% due to a larger share count following the IPO.

The board declared an interim dividend of 2.1p, up 1%, payable on 23 January.

Patient activity indicators also strengthened - new NHS patient referrals climbed 16% to 9,111, consultations rose 22% to 23,927 and the number of surgical procedures performed increased 17% to 4,009.

The group expanded its clinical footprint, adding consultants and increasing both outreach clinics and surgical facilities.

One Health said high NHS waiting lists, industrial action and winter pressures continued to drive demand for independent sector capacity, with government policy promoting greater patient choice.

The company said it was progressing work on its first surgical hub in Scunthorpe, where planning approval had been secured, land had been acquired and a contractor appointed.

It said the hub was expected to broaden surgical capacity and enhance profitability once completed, with a one-year build time targeted.

Chief executive Adam Binns said the results underscored the company's momentum.

"We are delighted to deliver a strong first half with impressive growth across all key performance metrics and remain on track to meet market expectations for the full year," he said.

He added that the group was advancing preparatory work on the hub while final planning conditions were completed.

"We remain confident in meeting our expectation of a one-year build time, whether approval comes before the calendar year end or in early 2026," he said.

The board said it remained confident in delivering full-year revenue and EBITDA in line with market forecasts of £29.6m and £2.3m respectively.

At 1357 GMT, shares in One Health Group were down 1.69% at 229.07p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE